Literature DB >> 31518973

Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis.

Krishnan Ravindran1, John C Wellons2, Michael C Dewan2.   

Abstract

OBJECTIVE: The optimal revascularization for pediatric moyamoya for reducing the incidence of future stroke events remains to be determined.
METHODS: The authors conducted a search of PubMed, MEDLINE, Embase, and Web of Science electronic databases from inception until January 2019. The primary endpoint was the presence of a future ischemic stroke event. Secondary endpoints were angiographic outcomes as measured by postoperative Matsushima grade and clinical symptom persistence. Patients who underwent either direct or combined direct/indirect revascularization were classified into the direct cohort. Data from each study on presence of postoperative stroke events were used to generate standardized mean differences and 95% confidence intervals, which were combined using inverse variance-weighted averages of standardized mean differences in a random effects model.
RESULTS: Twenty-nine studies met the inclusion criteria for analysis, comprising 2258 patients (1011 males, mean age 8.3 ± 1.8 years) who were followed up clinically for an average of 71.4 ± 51.3 months. One hundred fifty-four patients underwent direct bypass alone, 680 patients underwent either direct or combined direct/indirect revascularization procedures, while 1424 patients underwent indirect bypass alone. The frequencies of future stroke events in patients undergoing direct bypass alone, combined bypass, or indirect bypass alone were 1 per 190.3 patient-years, 1 per 108.9 patient-years, and 1 per 61.1 patient-years, respectively, in each cohort. The estimated stroke rates were 9.0% with indirect revascularization, 4.5% with direct revascularization alone, and 6.0% with combined revascularization. A forest plot did not reveal any significant differences in the incidence of future stroke events or angiographic outcomes following direct-only, combined, or indirect-only revascularization.
CONCLUSIONS: Direct, indirect, and combined indirect/direct bypass techniques are all effective revascularization options for pediatric moyamoya disease. A relative paucity of granular studies-and inherent surgical selection bias-limits direct comparison between interventions. Suitably designed prospective cohort studies may be useful in identifying patients likely to receive benefit from specific procedures.

Entities:  

Keywords:  CI = confidence interval; EDAMS = encephaloduroarteriomyosynangiosis; EDAS = encephaloduroarteriosynangiosis; EGS = encephalogaleosynangiosis; EMS = encephalomyosynangiosis; ES = effect size; MCA = middle cerebral artery; OR = odds ratio; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RR = relative risk; STA = superficial temporal artery; TIA = transient ischemic attack; direct bypass; encephaloduroarteriosynangiosis; indirect bypass; revascularization; vascular disorders

Year:  2019        PMID: 31518973     DOI: 10.3171/2019.6.PEDS19241

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  Moyamoya disease and syndrome: a review.

Authors:  Zeferino Demartini; Bernardo Ca Teixeira; Gelson Luis Koppe; Luana A Maranha Gatto; Alex Roman; Renato Puppi Munhoz
Journal:  Radiol Bras       Date:  2022 Jan-Feb

2.  Pediatric Stroke from Bench to Bedside: A Single-Center Experience in Saudi Arabia.

Authors:  Abdulaziz Mohammad Al-Sharydah; Hussain Khalid Al-Arfaj; Sari Saleh Al-Suhibani; Fahad Safran Al-Safran; Abdulrahman Hamad Al-Abdulwahhab; Saeed Ahmad Al-Jubran; Abdulhadi Ahmad AlSaflan
Journal:  Vasc Health Risk Manag       Date:  2022-07-13

3.  Risk factors for postoperative ischemic complications in pediatric moyamoya disease.

Authors:  Xiaofeng Deng; Peicong Ge; Rong Wang; Dong Zhang; Jizong Zhao; Yan Zhang
Journal:  BMC Neurol       Date:  2021-06-22       Impact factor: 2.474

Review 4.  Pediatric Stroke: Overview and Recent Updates.

Authors:  Mary Hollist; Katherine Au; Larry Morgan; Padmashri A Shetty; Riddhi Rane; Abraham Hollist; Angela Amaniampong; Batool F Kirmani
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

Review 5.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.